Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of L-Arginine supplementation on insulin resistance, sugar and lipid profile
IRCT2012071010240N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Apr 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in type 2 diabetes mellitus (T2DM), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Insulin resistance, Blood glucose and 1 more. Started Apr 2013; status: completed.
02
Drugs
arginine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2012071010240N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012071010240N1.